Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) EBT Margin (2016 - 2025)

Dexcom (DXCM) has disclosed EBT Margin for 16 consecutive years, with 27.05% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 807.0% to 27.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 23.35% through Dec 2025, up 577.0% year-over-year, with the annual reading at 23.35% for FY2025, 577.0% up from the prior year.
  • EBT Margin for Q4 2025 was 27.05% at Dexcom, down from 29.13% in the prior quarter.
  • The five-year high for EBT Margin was 29.13% in Q3 2025, with the low at 0.92% in Q4 2021.
  • Average EBT Margin over 5 years is 16.59%, with a median of 17.53% recorded in 2021.
  • The sharpest move saw EBT Margin crashed -2619bps in 2021, then surged 1542bps in 2022.
  • Over 5 years, EBT Margin stood at 0.92% in 2021, then soared by 1683bps to 16.34% in 2022, then surged by 46bps to 23.8% in 2023, then dropped by -20bps to 18.98% in 2024, then skyrocketed by 43bps to 27.05% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 27.05%, 29.13%, and 20.84% for Q4 2025, Q3 2025, and Q2 2025 respectively.